Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Found vs OurView Health

Found
Graded #14

Higher grade

vs+15.900000000000006
OurView Health
Graded #162

Lower grade

The verdict

Found takes it — 83.5/100 to 67.6/100.

Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The broadest medication bench on the board — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFound +2
78
76
Dose & formulationFound +30
94
64
Clinical oversightFound +7
86
79
Labs & monitoringFound +29
82
53
FulfillmentFound +14
84
70
Contract termsFound +25
70
45
Found · left barOurView Health · right bar

The numbers

MetricFoundOurView Health
WeighScore83.5/10067.6/100
GradeBC
Scorecard rank#14#162
SemaglutideCompounded from $99/mo$75/mo (starting dose, compounded)
TirzepatideCompounded from $99/mo$135/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Found

Graded #14 · B

Strengths

  • Widest medication list on this board — compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
  • Flat pricing as the dose increases, so a titration does not raise the monthly cost
  • Bills insurance for the clinical visits — the site states most members pay under $30 per visit
  • Runs a dedicated GLP-1 microdose programme for people who want a lower starting dose

Where it loses points

  • The $99/mo headline is a longer-plan floor — Found's own FAQ says 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
  • Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
  • The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
  • Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are
OurView Health

Graded #162 · C

Strengths

  • Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
  • Clear product pricing with no contracts; medication shipped to your door (30-day supply)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
  • Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)

Where it loses points

  • A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
  • Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard